GlycoMimetics Inc (GLYC)
0.2716
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.2711
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Cash and Short Term Investments (Quarterly): 31.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 31.28M |
December 31, 2023 | 41.79M |
September 30, 2023 | 49.41M |
June 30, 2023 | 58.04M |
March 31, 2023 | 65.00M |
December 31, 2022 | 47.87M |
September 30, 2022 | 51.62M |
June 30, 2022 | 60.24M |
March 31, 2022 | 76.52M |
December 31, 2021 | 90.25M |
September 30, 2021 | 101.92M |
June 30, 2021 | 118.85M |
March 31, 2021 | 132.47M |
December 31, 2020 | 137.04M |
September 30, 2020 | 142.87M |
June 30, 2020 | 149.84M |
March 31, 2020 | 154.82M |
December 31, 2019 | 158.20M |
September 30, 2019 | 170.89M |
June 30, 2019 | 184.17M |
March 31, 2019 | 195.56M |
December 31, 2018 | 209.92M |
September 30, 2018 | 219.83M |
Date | Value |
---|---|
June 30, 2018 | 229.43M |
March 31, 2018 | 242.63M |
December 31, 2017 | 123.92M |
September 30, 2017 | 112.87M |
June 30, 2017 | 119.15M |
March 31, 2017 | 34.59M |
December 31, 2016 | 40.04M |
September 30, 2016 | 45.28M |
June 30, 2016 | 53.09M |
March 31, 2016 | 38.83M |
December 31, 2015 | 46.80M |
September 30, 2015 | 53.76M |
June 30, 2015 | 40.23M |
March 31, 2015 | 46.57M |
December 31, 2014 | 55.20M |
September 30, 2014 | 61.36M |
June 30, 2014 | 66.22M |
March 31, 2014 | 56.97M |
December 31, 2013 | 2.311M |
September 30, 2013 | 7.690M |
June 30, 2013 | 10.78M |
December 31, 2012 | 17.37M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
31.28M
Minimum
Mar 2024
184.17M
Maximum
Jun 2019
101.16M
Average
96.09M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Altimmune Inc | 182.02M |
Lyell Immunopharma Inc | 526.30M |
Amicus Therapeutics Inc | 239.60M |
InfuSystems Holdings Inc | 0.822M |
Nanoviricides Inc | 3.257M |